Shares of CONMED Co. (NYSE:CNMD – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six analysts that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year price target […]